| 592688 |
FRONTIERS IN ENDOCRINOLOGY |
Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background |
2020-09-23 |
10.3389/fendo.2020.555685 |
Bergamin Carla Sanchez, Pérez-Hurtado Elizabeth, Oliveira Luanda, Gabbay Monica, Piveta Valdecira, Bittencourt Célia, Russo Denise, Carmona Rita de Cássia, Sato Maria, Dib Sergio A. |
| 592687 |
PHARMACEUTICS |
Patient-Centric Medicine Design: Key Characteristics of Oral Solid Dosage Forms that Improve Adherence and Acceptance in Older People |
2020-09-23 |
10.3390/pharmaceutics12100905 |
Shariff Zakia, Kirby Daniel, Missaghi Shahrzad, Rajabi-Siahboomi Ali, Maidment Ian |
| 592686 |
BMC CANCER |
High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin |
2020-09-23 |
10.1186/s12885-020-07390-3 |
Huh Gunn, Ryu Ji Kon, Chun Jung Won, Kim Joo Seong, Park Namyoung, Cho In Rae, Paik Woo Hyun, Lee Sang Hyub, Kim Yong-Tae |
| 592685 |
ONCOLOGY LETTERS |
Chronic exposure to the gibberellin derivative GA‑13315 sensitizes breast cancer MCF‑7 cells but not colon cancer HCT116 cells to irinotecan |
2020-09-23 |
10.3892/ol.2020.12144 |
Cheng Xianliang, Wang Guohui, Liao Yuan, Mo Jiao, Qing Chen |
| 592684 |
ONCOLOGY LETTERS |
miR‑1301‑3p promotes the proliferation and migration of lung cancer cells via direct repression of polymerase I and transcript release factor |
2020-09-23 |
10.3892/ol.2020.12149 |
Wu Yun, Shen Qianwen, Chen Xiaoyu, Wu Yue, Niu Yuxu, Lv Fanzhen |
| 592683 |
ONCOLOGY LETTERS |
MicroRNA‑1297 downregulation inhibits breast cancer cell epithelial‑mesenchymal transition and proliferation in a FA2H‑dependent manner |
2020-09-23 |
10.3892/ol.2020.12140 |
Li Hong, Lian Bin, Liu Yaobang, Chai Dahai, Chai Dahai, Li Jinping |
| 592682 |
FRONTIERS IN ONCOLOGY |
An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma |
2020-09-23 |
10.3389/fonc.2020.543997 |
Kumar Vipin, Ray Sandipan, Ghantasala Saicharan, Srivastava Sanjeeva |
| 592681 |
ONCOLOGY LETTERS |
Inhibition of invadopodia formation by diosgenin in tumor cells (Review) |
2020-09-23 |
10.3892/ol.2020.12148 |
Lian Yaxin, Wen Dezhong, Meng Xiaoting, Wang Xiaozhen, Li Hongcheng, Hao Liming, Xue Hui, Zhao Jia |
| 592680 |
ONCOLOGY LETTERS |
Carcinogenic effects of bisphenol A in breast and ovarian cancers (Review) |
2020-09-23 |
10.3892/ol.2020.12145 |
Dumitrascu Mihai, Mares Cristian, Petca Razvan-Cosmin, Sandru Florica, Popescu Razvan-Ionut, Mehedintu Claudia, Petca Aida |
| 592679 |
FRONTIERS IN ONCOLOGY |
Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma |
2020-09-23 |
10.3389/fonc.2020.564631 |
He Xiaobo, Mao Xiaopeng, Li Jibin, Guo Shengjie |
